Takeda Pharmaceutical (TAK) Net Income (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Net Income of $1.3 billion for Q2 2026, up 8.83% year-over-year from $1.2 billion in Q2 2025, and down 1.62% quarter-over-quarter from $1.4 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Net Income (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Net Income history runs 10 years deep, the most recent figure standing at $1.3 billion for Q2 2026.
- In Q2 2026, Net Income rose 8.83% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.9 billion (down 49.6% YoY), while the FY2026 annual figure was -$1.0 billion, down 242.35% from the prior year.
- Net Income for Q2 2026 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
- The five-year high for Net Income was $2.8 billion in Q3 2025, with the low at -$3.5 billion in Q4 2025.
- The 5-year median for Net Income is $1.3 billion (2025), against an average of $1.0 billion.
- The sharpest annual moves came in 2023 and 2024: Net Income surged 297.92% in 2023, then sank 4440.99% in 2024.
- Takeda Pharmaceutical's Net Income stood at $673.6 million in 2022, then plunged by 96.58% to $23.0 million in 2023, then tumbled by 4440.99% to -$998.5 million in 2024, then plunged by 252.45% to -$3.5 billion in 2025, then soared by 137.83% to $1.3 billion in 2026.
- Business Quant data shows TAK's Net Income at $1.3 billion in Q2 2026, $1.4 billion in Q1 2026, and -$3.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Bn |
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | -3.52 Bn |
| Sep 30, 2025 | 2.78 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | -998.51 Mn |
| Sep 30, 2024 | 2.37 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 1.32 Bn |
| Mar 31, 2023 | 1.56 Bn |
| Dec 31, 2022 | 673.55 Mn |
| Sep 30, 2022 | 487.77 Mn |
| Jun 30, 2022 | 1.59 Bn |
| Mar 31, 2022 | 2.65 Bn |
| Dec 31, 2021 | 761.54 Mn |
| Sep 30, 2021 | 698.55 Mn |